Esophageal Cancer
Conditions
Keywords
stage 0 esophageal cancer, stage I esophageal cancer, stage II esophageal cancer, stage III esophageal cancer, stage IV esophageal cancer
Brief summary
RATIONALE: Gathering information about genes, cigarette smoking, and diet may help doctors learn more about risk factors that may cause esophageal cancer. PURPOSE: This clinical trial is studying genetic and environmental risk factors related to esophageal cancer.
Detailed description
OBJECTIVES: * Examine the role of several genetically-determined factors in combination with cigarette smoking and diet in the etiology and prevention of esophageal cancer. * Identify polymorphisms in metabolizing enzymes (e.g., phase I or II metabolism \[GSTM1, GSTT1,CYP1A1, CYP3A5, mEH, NQO1, GSTP1\], DNA repair \[XRCC1, ERCC2\], free-radical formation \[MPO, MnSOD\], inflammatory genes \[ IL1-beta\], metastatic potential \[MMP1\], and cell cycle or tumor suppression \[p21, p53\]) and related path genes of susceptibility for esophageal cancer. OUTLINE: Blood and tumor tissue samples are collected. DNA purified from these samples is analyzed using DNA-based assays to determine polymorphisms in various related gene pathways. Patients complete questionnaires concerning environmental, smoking and diet habits. PROJECTED ACCRUAL: A total of 1,000 tissue samples from patients and healthy participants (750 patients and 250 healthy participants) will be accrued for this study.
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
DISEASE CHARACTERISTICS: * Meets 1 of the following criteria: * Diagnosis of esophageal cancer (patient) * Newly diagnosed disease * Receiving care at Massachusetts General Hospital, Thoracic Oncology Center * Friend or spouse of patient (healthy participants) PATIENT CHARACTERISTICS: * No concurrent psychiatric incapacity or dementia PRIOR CONCURRENT THERAPY: * Not specified
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analyses of dietary factors and Helicobacter pylori infection (previous vs current) | 2000-2016 |
| Polymorphisms in various pathways, DNA repair, free-radical formation, inflammatory genes, metastatic potential, and cell cycle or tumor suppression in blood samples | 2000-2016 |
| Comparison of presence or absence of variant polymorphisms between cases and controls | 2000-2016 |
| Correlation between polymorphisms in blood samples and polymorphisms in tissue specimens | 2000-2016 |
Countries
United States